The 4th Annual University of California Hematologic Malignancies Consortium (UCHMC) Research Symposium is a collaboration across the five University of California Cancer Centers to highlight clinical trial research being done across the UC system.
The symposium will include discussions on opportunities for collaboration across the UC system, translating recent laboratory discoveries into new therapies, application of novel therapies in hematologic malignancies, and ongoing clinical trials currently being conducted by the UC Hematologic Malignancies Consortium.
Attendees will gain an understanding of how basic research discoveries are being translated into clinical trials, gain a better understanding of best practice in the management of hematologic malignancies and to become familiar with targeted and immunotherapeutic approaches for the treatment of hematologic malignancies.
Thursday, September 19, 2019: Disease team meetings will be held during the day for members of the academic community. In the afternoon, a UCHMC Disease teamwide meeting will be held for industry participants. The day will conclude with an optional networking cocktail reception from 5 to 7 p.m.
Friday, September 20, 2019: Presentations from members of the UC community will be held throughout the day. Please note that continuing medical education (CME) credit will only be available for attendance on Friday, September 20, 2019.
For more information, please visit http://www.uchmc.org/
